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Patients With Definite and Inconclusive Evidence
of Reflux According to Lyon Consensus Display
Similar Motility and Esophagogastric Junction
Characteristics
Mentore Ribolsi,1* Edoardo Savarino,2 Benjamin Rogers,3 Arvind Rengarajan,3 Marco Della Coletta,2 Matteo Ghisa,2
Michele Cicala,1 and C Prakash Gyawali3
1
Unit of Gastroenterology, Campus Bio Medico University, Rome, Italy; 2Division of Gastroenterology, Department of Surgical, Oncological
and Gastroenterological Sciences, University of Padua, Padua, Italy; and 3Division of Gastroenterology, Department of Medicine, Washington
University School of Medicine, St. Louis, MO, USA

Background/Aims
The role of esophageal high-resolution manometry (HRM) within Lyon consensus phenotypes, especially patients with inconclusive
gastroesophageal reflux disease (GERD) evidence, has not been fully investigated. In this multicenter, observational study we aim to
compare HRM parameters in patients with GERD stratified according to the Lyon consensus.
Methods
Clinical and endoscopic data, HRM and multichannel intraluminal impedance-pH (MII-pH) studies performed off proton pump
inhibitor therapy in patients with esophageal GERD symptoms were reviewed. Lyon consensus criteria identified pathological GERD,
reflux hypersensitivity, functional heartburn, and inconclusive GERD. Patients, with inconclusive GERD were further subdivided into 2
groups based on total reflux numbers (≤ 80 or > 80 reflux episodes) during the MII-pH recording time.
Results
A total of 264 patients formed the study cohort. Pathological GERD and inconclusive GERD patients were associated with higher
numbers of reflux episodes, lower mean nocturnal baseline impedance (MNBI) values, and a higher proportion of patients with
pathologic MNBI compared to functional heartburn (P < 0.05 for each comparison). On multivariate analysis, pathological GERD and
inconclusive GERD patients, both with ≤ 80 or > 80 reflux episodes, were significantly associated with pathologic esophagogastric
junction contractile integral values and with presence of hiatus hernia (type 2/3 esophagogastric junction). Patients with inconclusive
GERD and > 80 reflux episodes were significantly associated with fragmented peristalsis and ineffective esophageal motility whilst
inconclusive GERD with ≤ 80 reflux episodes were significantly associated with fragmented peristalsis.
Conclusion
Esophageal motor parameters on HRM are similar between pathologic and inconclusive GERD according to the Lyon consensus.
(J Neurogastroenterol Motil 2021;27:565-573)
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Introduction
Gastroesophageal reflux disease (GERD) represents one of the
most common gastrointestinal disorders, with an increasing worldwide prevalence.1-4 The recent Lyon consensus delineates parameters on ambulatory reflux monitoring that categorically establish
and rule out the presence of GERD.5 However, acid exposure time
(AET) between 4% and 6% is defined as inconclusive GERD5
where adjunctive investigative modalities and metrics,6-9 including
endoscopy, histology, high-resolution manometry (HRM), and
novel impedance metrics, may either confirm or refute the diagnosis
of GERD. In particular, low mean nocturnal baseline impedance
(MNBI) has been demonstrated to identify patients with borderline AET who respond to anti-reflux therapy.10
Metrics extracted from HRM may add confidence to a diagnosis of pathologic GERD when AET is borderline.11 HRM evaluates pathophysiological factors relevant to GERD11,12 by providing
detailed characterization of esophagogastric junction (EGJ) morphology,13 better understanding of the role of EGJ barrier function
using the EGJ-contractile integral (EGJ-CI),14-16 and description of
esophageal body motor function in the context of reflux clearance.17
Fragmented and failed swallows on HRM associate with abnormal
reflux burden,18 and large breaks in esophageal peristaltic integrity,
which are often identified in GERD-related chronic cough,19,20 associate with prolonged supine reflux clearance, higher AET, and
erosive esophagitis.21
Despite potential value in understanding GERD pathophysiology, the role of HRM within Lyon consensus phenotypes, especially in patients with inconclusive GERD evidence, has not been fully
investigated. The present investigation is a multicenter, observational study aimed at evaluating and comparing HRM parameters
in patients with GERD stratified according to the Lyon consensus.

Materials and Methods

Symptom Assessment
While esophageal symptoms (heartburn, regurgitation, and
chest pain) were required for study inclusion, the presence of co-existing extra-esophageal symptoms (chronic cough, asthma, hoarseness, and globus) was also recorded. Esophageal symptom burden
was assessed within the previous year on validated institutional
questionnaires25-28 at each study site. While each center used its own
set of questionnaires, the common element in the various questionnaires used was a 100 mm visual analog scale (VAS) where the
patient was asked to make a mark on the 100 mm line as to where
their symptoms were in the preceding 2 weeks (0 = no symptoms
and 100 = worst possible symptoms). VAS scales are a validated
tool for assessment of change in perceptive symptoms and function
within several domains, including gastrointestinal symptoms.29,30
VAS scales have been utilized in the assessment and follow-up of
esophageal symptoms in the GERD context.10,31,32

Esophageal High-resolution Manometry

Patients
In this retrospective observational study, consecutive adult
patients (age > 18 years) evaluated at 3 centers (2 in Italy and 1 in
the United States) over a 2-year period (2017-2019) with esophageal HRM and ambulatory 24-hour multichannel intraluminal
impedance-pH (MII-pH) monitoring were eligible for inclusion.
Specific inclusion criteria were the presence of dominant esophageal
symptoms (heartburn, regurgitation, and non-cardiac chest pain)22
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unresponsive to acid suppressive therapy or requiring reflux testing
to confirm the need for long-term proton pump inhibitor therapy
as well as to document reflux presence prior to anti-reflux surgery
in patients with persisting symptoms. Inclusion in this study also
required ambulatory MII-pH studies, performed off acid-suppressive therapy (after at least 7 days pharmacological wash-out)23
and the presence of 10 supine water swallows for HRM analysis,
performed with Chicago classification version 3.0 (CC v3.0).24
Individuals with inadequate evaluation (equipment malfunction,
poor study quality, and presence of artifacts) were not included.
Moreover, patients with evidence of integrated relaxation pressure > 15 mmHg, connective tissue disease, history of neoplasia,
and prior foregut surgery were excluded. The study protocol was
approved by the institutional review board of the 3 University
Centers, and each collaborating institution completed data sharing
agreements for analysis of de-identified demographic, clinical, MIIpH, and HRM data (IRB 201607083).

HRM was used to localize lower esophageal sphincter (LES)
for optimal positioning of pH-impedance catheters, performed
on the same day as the MII-pH study. A catheter with 36 circumferential solid state pressure sensors, located at 1-cm intervals
(Medtronic, Duluth, GA, USA) was inserted, after an overnight
fast, through an anesthetized nostril such that at least 3 distal pressure sensors were positioned in the stomach. Medications with
potential to affect esophageal motility (metoclopramide, anticholinergics, calcium blockers, and opioids) were held whenever possible
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and for the safety of the patient. HRM studies were performed
using ten 5 mL swallows of ambient temperature fluid at 30-second
interval in a semi-recumbent position.33
HRM studied were evaluated according CC v3.0 criteria24: (1)
intact swallow: distal contractile integral (DCI) > 450 mmHg·cm·sec;
(2) fragmented swallow: DCI > 450 mmHg·cm·sec with > 5 cm
breaks; (3) weak swallow: DCI 100-450 mmHg·cm·sec; (4) failed
swallow: DCI < 100 mmHg·cm·sec. CC v3.0 diagnoses consisted
of the following: (1) fragmented peristalsis: ≥ 50% fragmented
swallows; (2) ineffective esophageal motility (IEM): ≥ 50% of any
combination of weak or failed swallows; and (3) absent contractility:
100% failed swallows.
EGJ-CI was measured using a DCI like tool, during a period of quiet rest over exactly 3 respiratory cycles, and divided
by the duration of the respiratory cycles to make the metric
independent of respiration. EGJ-CI was considered low when
< 39.1 mmHg·cm.14,15 EGJ morphology was assessed considering the relationship between LES and crural diaphragm; type 1
when LES and crural diaphragm were superimposed, type 2 when
separated < 3 cm, and type 3 when separated ≥ 3 cm.14

24-Hour Multichannel Intraluminal Impedance-pH
Monitoring
MII-pH was recorded using a 2.3 mm diameter polyvinyl
catheter assembly containing a series of impedance electrodes, each
4 mm in axial length, spaced at 2-cm intervals, and a distal antimony pH electrode (Sandhill Scientific Inc, Highlands Ranch, CO,
USA). The pH electrodes were calibrated using pH 4.0 and pH
7.0 buffer solutions before MII-pH monitoring. Following HRM,
the catheter was passed through the anesthetized nostril, and positioned with the pH electrode 5 cm above the LES, and impedance
electrodes at 3, 5, 7, 9, 15, and 17 cm proximal to the LES. Event
markers, corroborated with paper diaries, were used to record
symptoms, meal times, and supine periods. AET was defined as
pathological if the time pH < 4 exceeded 6% of the total recording
time.4 Reflux-symptom association was assessed using symptom association probability (SAP) for all reflux episodes using previously
described methodology.34-36 MNBI was calculated by measuring
baseline impedance values at 3 cm above the LES, across stable
nocturnal 10-minute periods (at or around 1 AM, 2 AM, and 3
AM).37 The values from the 3 time periods were averaged to yield
the MNBI for each channel, and values < 2292 ohms defined abnormally low MNBI.37,38

Patient Phenotypes
According to MII-pH findings, patients with AET > 6% or
with grade C-D erosive esophagitis were defined as having pathological GERD. Patients with AET between 4% and 6% and with a
negative SAP, were categorized into the inconclusive GERD group.
Patients with AET ≤ 6% but with a positive SAP were diagnosed
as reflux hypersensitivity (RH). All patients with AET ≤ 4% and
with a negative SAP were classified as functional heartburn (FH).
For comparison purposes, patients with RH and FH were retained
in the study. HRM data were evaluated in all patients; those with
inconclusive GERD were further subdivided into 2 groups according to the total number of reflux episodes during the MII-pH
recording period (≤ 80 or > 80 reflux episodes).

Statistical Methods
Data are presented as median and interquartile range unless
otherwise indicated. Comparisons between groups were assessed
using the Fisher’s exact test. Group means were compared using
Mann-Whitney U test, with Bonferroni correction for multiple
comparisons when appropriate. Multivariate regression models
were generated to evaluate the association between each GERD
phenotype and HRM findings. Significance was achieved when
the P -value was < 0.05. SPSS 16.0 software (SPSS Inc, Chicago,
IL, USA) was used to perform statistical analysis.

Results
Study Population
A total of 264 patients (165 female; mean age 47 years, range
19-73 years) with esophageal symptoms fulfilled inclusion criteria
and formed the study cohort. In addition to esophageal symptoms
in all patients, extra-esophageal symptoms were reported by approximately a third of patients (chronic cough 24%, asthma 5%, hoarseness 9%, and globus 7%). A total of 24 patients had erosive reflux
disease (ERD) (15 grade A, 7 grade B, and 2 grade C according to
Los Angeles classification). Endoscopically identified hiatus hernia
was detected in 51 out of 264 patients (19%).
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Pathological GERD and inconclusive GERD groups presented a significantly higher proportion of patients with abnormally
low MNBI at 3 cm compared to FH group (P < 0.005 for each
comparison). Pathological GERD group was also characterized by
a significantly higher proportion of patients with abnormal MNBI
at 3 cm compared to RH group (P = 0.048) (Fig. 1A).

Multichannel Intraluminal Impedance-pH Data in
Patients With Pathological Gastroesophageal Reflux
Disease, Inconclusive Gastroesophageal Reflux
Disease, Reflux Hypersensitivity, and Functional
Heartburn
Seventy-three patients were classified as having pathological
GERD. There were 40 patients in the inconclusive GERD group,
59 had RH and 92 had FH. Patients with pathological GERD
demonstrated a significantly higher total AET and AET during
supine position compared to patients with inconclusive GERD.
Patients with pathological GERD and inconclusive GERD
were characterized by a significantly higher median number of
reflux episodes compared to patients with FH (P < 0.05 for each
comparison; Table 1). Pathological GERD patients had a significantly higher median number of reflux episodes compared to RH
patients (P < 0.05). Patients with pathological GERD and inconclusive GERD displayed a significantly lower 3 cm MNBI values
compared to patients with FH (Table 1).

High-resolution Manometry Data in Patients With
Pathological Gastroesophageal Reflux Disease,
Inconclusive Gastroesophageal Reflux Disease,
Reflux Hypersensitivity, and Functional Heartburn
HRM data were evaluated in patients with pathological
GERD, inconclusive GERD, RH, and FH, the latter subdivided
into 2 groups according to the total reflux number during the MIIpH recording time (≤ 80 or > 80 reflux episodes). Patients with
pathological GERD, inconclusive GERD ≤ 80 reflux episodes,
inconclusive GERD > 80 reflux episodes, and RH demonstrated
significantly lower median basal LES pressure (P = 0.008, P =
0.040, P = 0.040, and P = 0.001, respectively) and EGJ-CI

Table 1. Multichannel Intraluminal Impedance-pH Data in the Studied Groups

Variables

Pathological GERD
(n = 73)

Inconclusive GERD
(n = 40)

RH
(n = 59)

FH
(n = 92)

AET (%)
AET supine (%)
Reflux episodes
MNBI (Ω)

10.0 (8.3)a
5.9 (4.2)a
72 (52)b
1870 (1651)c

4.6 (0.9)
1.8 (0.4)
65 (45)b
1657 (1354)c

3.1 (3.2)
1.6 (0.9)
47 (34)
2443 (1450)

1.2 (1.5)
0.7 (0.5)
46 (34)
2324 (1615)

GERD, gastroesophageal reflux disease; RH, reflux hypersensitivity; FH, functional heartburn; AET, acid exposure time; MNBI, mean nocturnal baseline impedance.
a
P < 0.001 vs inconclusive GERD, RH, and FH; bP < 0.05 vs FH; cP < 0.05 vs FH.
Data are presented as median (interquartile range [IQR]).
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Figure 1. Proportion of patients with pathologic value of mean nocturnal baseline impedance (MNBI) at 3 cm (A), and esophagogastric junction
contractile integral (EGJ-CI) and type 2/3 esophagogastric junction (EGJ) (B) in the studied groups. RH, reflux hypersensitivity; FH, functional
heartburn. *P < 0.05 vs FH; **P < 0.005 vs FH; ***P < 0.001 vs FH.
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Table 2. High-resolution Manometry Data in the Study Groups

Variables

Pathological GERD
( n = 73)

Inconclusive
GERD ≤ 80
(n = 23)

Inconclusive
GERD > 80
(n = 17)

RH
(n = 59)

FH
(n = 92)

Basal LES pressure (mmHg)
IRP (mmHg)
EGJ-CI (mmHg·cm)
DCI (mmHg·cm·sec)

19.2 (13.7)a
9.1 (6.5)
14.0 (11.8)b
555 (1262)b

14.8 (8.9)a
9.0 (5)
22.9 (30.1)b
1343 (1887)

14.2 (15.3)a
7.3 (5.8)
14.2 (15.3)b
1019 (724)

16.3 (11.8)a
7.5 (6.4)
17.0 (17.7)b
1812 (1757)

25.7 (13.9)
9.0 (4.4)
47.0 (33.0)
2105 (2553)

GERD, gastroesophageal reflux disease; RH, reflux hypersensitivity; FH, functional heartburn; LES, lower esophageal sphincter; IRP, integrated relaxation pressure; EGJ-CI, esophagogastric junction contractile integral; DCI, distal contractile integral.
a
P < 0.05 vs FH; bP < 0.01 vs FH.
Data are presented as median (interquartile range [IQR]).

values (P = 0.006, P < 0.001, P < 0.001, and P = 0.002, respectively) compared to patients with FH, while median integrated
relaxation pressure values were comparable between the groups
(Table 2).
Median DCI values were significantly lower in pathological
GERD compared to FH patients (P = 0.001). Median DCI
values in patients with inconclusive GERD ≤ 80 reflux episodes,
inconclusive GERD > 80 reflux episodes, and RH were lower
compared to patients with FH, although these differences were
not different (P = 0.370, P = 0.120, and P = 0.070, respectively;
Table 2).
Pathological GERD, inconclusive GERD ≤ 80 reflux episodes, inconclusive GERD > 80 reflux episodes, and RH groups
had significantly higher proportions of patients with pathologic
EGJ-CI or hiatus hernia (type 2/3 EGJ) compared to FH group (P
< 0.05 for each comparison). Proportions of patients with pathologic EGJ-CI were similar among pathological GERD, inconclusive GERD > 80, and RH groups.
Pathological GERD and inconclusive GERD > 80 reflux
episodes groups presented similar proportions of patients with type
2/3 EGJ, and a significantly higher proportion compared to inconclusive GERD ≤ 80 reflux episodes and RH groups (Fig. 1B).
Inconclusive GERD > 80 reflux episodes and pathological
GERD groups had significantly higher proportions of patients with
hiatus hernia (type 2/3 EGJ) compared to RH group with AET
between 4% and 6% (73%, 82%, and 43%, respectively; P < 0.01).
Proportions of patients with pathologic EGJ-CI were similar between pathological GERD, inconclusive GERD > 80 reflux episodes, and RH with AET between 4% and 6% groups (87%, 88%,
and 86%, respectively). Proportions of patients with hypomotility
features were higher in pathological GERD, inconclusive GERD
> 80 reflux episodes, and inconclusive GERD ≤ 80 reflux episodes compared to RH with AET between 4% and 6% groups,

Table 3. Multivariate Analysis Results Comparing Esophagogastric

Junction Metrics
Patients
Pathological GERD

Inconclusive GERD ≤ 80
Inconclusive GERD > 80
RH

EGJ-CI
OR (95% CI)

Type 2/3 EGJ
OR (95% CI)

4.4 (1.2-15.4)
2.6 (1.2-10.9)
6.5 (2.7-15.4)
6.6 (2.9-14.7)

3.9 (1.2-12.6)
4.1 (1.4-11.9)
7.2 (3.0-16.2)

1.9 (0.8-4.4)

EGJ-CI, esophagogastric junction contractile integral; GERD, gastroesophageal reflux disease; RH, reflux hypersensitivity.

although these differences were not significant (49%, 53%, 40%,
and 29% respectively).
On multivariate analysis, in comparison to FH group, patients
with pathological GERD and inconclusive GERD both with ≤ 80
or > 80 reflux episodes were significantly associated with pathologic EGJ-CI and hiatus hernia (type 2/3 EGJ). RH was significantly
associated only with pathologic EGJ-CI (Table 3).
In the pathological GERD group, and inconclusive GERD
groups with both ≤ 80 and > 80 reflux episodes, a significantly
higher proportion of patients had evidence of esophageal body hypomotility features (absent peristalsis, fragmented peristalsis, and
IEM) compared to the FH group (P < 0.005 for each comparison) (Fig. 2). Pathological GERD and inconclusive GERD > 80
groups were also characterized by a significantly higher proportion
of patients with esophageal body hypomotility compared to patients
with RH (P < 0.001 and P < 0.005, respectively).
On multivariate analysis, in comparison to the FH group,
pathological GERD was significantly associated with presence of
absent peristalsis, fragmented peristalsis, and IEM. The inconclusive GERD group with > 80 reflux episodes was significantly
associated with presence of fragmented peristalsis and IEM. Inconclusive GERD with ≤ 80 reflux episodes was significantly associ-
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ated with presence of fragmented peristalsis. Diagnosis of RH had
no association with presence of IEM (Table 4).

Discussion
In this retrospective observational study, we compared HRM
parameters in pathological GERD, RH, and FH as well as in
patients with inconclusive evidence of GERD. Our results show,
for the first time, that both pathologic GERD and inconclusive
GERD phenotypes are characterized by similar EGJ metrics and
morphology. Additionally, we report that both pathologic GERD
and inconclusive GERD are associated with higher numbers of
reflux episodes, lower mean MNBI values, and a higher proportion
of patients with pathologic MNBI compared to FH, with the only
distinction between pathologic and inconclusive GERD being the
AET value. We describe characteristics within inconclusive GERD
that associate with abnormal HRM metrics, including > 80 reflux
episodes on MII-pH recordings. We conclude that a significant
proportion of inconclusive GERD potentially represents pathologic
GERD, and thus, the HRM findings supporting GERD patho60

Hypomotility features (%)

***
50
40

***
**

30
20
10
0
Pathological Inconclusive Inconclusive
GERD
GERD <80 GERD >80

RH

FH

Figure 2. Proportion of patients with hypomotility features in the
studied groups. RH, reflux hypersensitivity; FH, functional heartburn. ***P < 0.001 vs FH; **P < 0.005 vs FH.

physiology add confidence in the presence of pathologic GERD.
This is relevant, as patients with GERD undergoing catheter-based
reflux monitoring typically undergo HRM studies for LES localization, and proton pump inhibitor non-responders undergo HRM
studies are evaluated for achalasia, motor disorders, and behavioral
syndromes; therefore HRM information is available to be analyzed
and interpreted in these patients. Our findings support extracting
HRM metrics relevant to GERD in this context, since these may
provide additional GERD evidence as suggested by the Lyon consensus.
We selected a large cohort of patients with dominant esophageal
symptoms being evaluated to document reflux evidence. Patients
enrollment was symptom-based, to emulate the real world setting.
Our findings are in agreement with a recent study by Rengarajan et
al10 who showed that when low, MNBI is able to identify patients
with pathologic and borderline AET who respond to antireflux
therapy. Moreover, our results confirm that MNBI is able to increase the diagnostic yield of MII-pH monitoring in patients with
reflux disease and negatively correlates with AET.37-39 Our results
concerning DCI are in keeping with previously published data,
demonstrating that the vigor of the peristalsis during multiple rapid
swallows, measured using DCI, inversely correlates with AET in
patients with pathological GERD.40 This finding sustains the hypothesis, in keeping with previous studies,17-19 that lower peristaltic
vigor correlates with higher reflux burden, as observed in patients
with pathological GERD.
We demonstrate that pathologic GERD and inconclusive
GERD phenotypes are characterized by similar EGJ metrics and
morphology. Patients with > 80 reflux episodes in the context of
inconclusive GERD had similar proportions with abnormal EGJ
morphology and pathologic EGJ-CI compared to pathologic
GERD. Several published reports demonstrate that abnormal EGJ
metrics and presence of hiatal hernia at HRM are associated with
increased reflux burden.13-16 Similarly, low EGJ-CI is associated
with abnormal total and supine acid burden,14 as well as a higher
probability of positive MII-pH monitoring compared to normal

Table 4. Multivariate Analysis Results Comparing Esophageal Body Motor Function

Patients

Absent peristalsis
OR (95% CI)

Fragmented peristalsis
OR (95% CI)

IEM
OR (95% CI)

Pathological GERD
Inconclusive GERD ≤ 80
Inconclusive GERD > 80
RH

4.4 (1.2-15.4)
4.0 (0.8-14.2)
2.9 (0.3-25.4)
1.2 (0.2-5.9)

3.9 (1.2-12.6)
4.3 (1.1-17.9)
4.1 (1.4-9.7)
0.6 (0.1-3.4)

12.8 (3.6-22.4)
2.7 (0.2-16.1)
8.5 (3.2-15.3)
3.9 (0.9-7.1)

IEM, ineffective esophageal motility; GERD, gastroesophageal reflux disease; RH, reflux hypersensitivity.
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EGJ morphology; further, both EGJ morphology and EGJ-CI
independently predict esophageal reflux burden.15 Additionally,
esophageal body hypomotility features also were similar between
pathologic and inconclusive GERD, with similar high proportions
of IEM and fragmented peristalsis. Therefore, based on a similar
pattern of EGJ morphology, EGJ tone, and esophageal body hypomotility features, inconclusive GERD with > 80 reflux episodes is
phenotypically similar to pathologic GERD.
Our findings suggest that pathologic GERD and inconclusive GERD with > 80 reflux episodes share motor abnormalities
that may work in synergy with EGJ disruption or dysfunction. In
particular, while EGJ disruption or dysfunction is a primary pathophysiologic factor in determining reflux occurrence, esophageal
body motor function influences duration of contact of the refluxate
with the esophageal mucosa, accounting for delayed bolus transit
and reduced esophageal reflux clearance in patients with GERD.17
It has been shown that the presence of large breaks in esophageal
peristaltic integrity on HRM is associated with significantly prolonged supine reflux clearance, higher acid exposure time, and erosive esophagitis.19 Large breaks are often identified in the context of
suspected GERD-related chronic cough, the presence of which can
be associated with suboptimal benefit from antireflux therapy.20,21 It
has been recently demonstrated that fragmented and failed swallows
are correlated with abnormal reflux burden better than weak swallows.14 Finally, disruption of the EGJ and absent contractility on
HRM are both associated with lower MNBI values.41
It is conceivable to speculate that pathological GERD and inconclusive GERD patients, in particular those with > 80 refluxes
during MII-pH monitoring, share similar mechanisms of reflux
occurrence. In these patients, the presence of abnormal number of
reflux episodes or of pathologic AET may be related to impaired
EGJ function or esophageal peristalsis. It is well known that the
degree of the reflux burden depends also on several other factors
not evaluated in the present study, ie, the saliva buffer function or
the rate and duration of transient LES relaxation. Therefore we
think that motor findings, observed at HRM, interplay with other
mechanisms in determining the reflux burden.
One may speculate that within the spectrum of symptomatic
GERD, esophageal motor function plays a pivotal role in the
pathophysiology of pathological GERD and inconclusive GERD
patients; in contrast, esophageal visceral sensitivity rather than motor function has the key pathophysiologic role in patients with RH
and FH.42
The cutoff 4% and 6% of the AET has been proposed to better
define patients with or without pathological GERD, given the het-

erogeneous data in medical literature reporting the normal values
in terms of acid exposure among healthy subjects.4 More recently,
a publication from an international consortium highlighted that the
traditional cutoff of 4.2% was probably overestimated, and when
patients have AET values lower than 6% we should pay more attention on the diagnosis.43 Thus, more data are necessary to confirm
the conclusive diagnosis, particularly if surgery is suggested. In
keeping, our study suggests that patients with pathological GERD
and inconclusive GERD may be similar in terms of HRM pattern,
but further data such as the evaluation of other variables (ie, MNBI
or post-reflux swallow-induced peristaltic wave [PSPW]) may
be helpful in better understanding patients falling in the grey area.
Future studies confirming our findings are needed. Moreover, it
would be of interest to evaluate, in prospective studies, the outcome
to the therapy in this group of inconclusive GERD patients. It is
conceivable that all of these information will be helpful in clarifying
if the Lyon distinction makes sense.
To our knowledge, this is the first study aimed at evaluating
the HRM parameters in patients subdivided according to Lyon
consensus. Strengths of the present study are the number of patients
included and rigorous selection process. However, some limitations may temper the relevance of our findings. The main limitation
relates to the retrospective patient identification and data analysis
for the purpose of this multicenter study, despite the fact that data
collection was prospectively performed independent of the current
study across the 3 sites. Moreover, we could not address further
outcome following the performance of these esophageal tests. Additionally, additional test features potentially helpful to corroborate
our findings were not evaluated (ie, PSPW analysis, histology, etc).
A prospective study, with enrollment to each arm determined by
power calculations, would have provided more appropriate patient
numbers to show differences between groups. Finally, it is known
that MII-pH monitoring has a not negligible day-to-day variability
rate and this limits the usefulness of MII-pH in GERD diagnosing. Nevertheless, our findings demonstrate the value of esophageal
motor pathophysiology from HRM in the evaluation of patients
with esophageal symptoms, wherein motor abnormalities, both at
the EGJ and in the esophageal body, support GERD rather than a
functional esophageal disorder as the primary mechanism for symptoms.
In summary, our results demonstrate that patients with pathologic GERD and those with inconclusive evidence of reflux disease
are characterized by similar HRM parameters. In the clinical setting, our findings support the notion that patients with inconclusive
evidence of GERD potentially have true reflux disease. These
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results lead to the conclusion that HRM should be performed and
results should be taken into account in the evaluation and management of GERD patients.
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